The Carina surgical robotic system. | Supply: Ronovo Surgical
Ronovo Surgical introduced in the present day that it closed a brand new spherical of financing, bringing its complete funds raised to greater than $50 million since 2020.
Shanghai-based Ronovo develops broad, cross-specialty robotic-assisted surgical procedure (RAS) expertise. LongRiver Investments led the newest financing spherical. Present buyers Lilly Asia Ventures, Vivo Capital, Matrix Companions China and GGV Capital participated. CEC Capital acted because the unique monetary advisor.
Ronovo stated it now exits “stealth mode,” unveiling its inaugural Carina robotic platform. Carina, a modular system constructed on proprietary expertise, allows configurable robotic help for laparoscopic surgical procedures throughout a number of specialties.
Add Ronovo to a number of firms, giant and small, which are searching for to tackle Intuitive within the soft-tissue robotic surgical procedure area. (Here are 16 surgical robotics companies you need to know.)
The corporate stated its oversubscribed financing spherical accelerates the multi-discipline scientific trial for Carina. It additionally expects the funds to strengthen R&D and scientific purposes growth, in addition to bolster its expertise base.
Extra about Ronovo Surgical and its Carina system
Ronovo developed Carina in collaboration with famend Chinese language laparoscopic surgeons, based on a information launch. It addresses quite a few ache factors in minimally invasive surgical procedures and offers surgeons with the flexibleness to decide on one of the best devices and essentially the most excellent anatomical entry. As such, surgeons can leverage prior laparoscopic coaching and enhance upon their surgical efficiency, the corporate stated.
The corporate famous that Carina minimizes gear footprint to maximise the utilization of working room area. Surgical groups can select between three-module or four-module configurations, Ronovo stated. Surgeons even have a full suite of devices from which to decide on with Carina.
“We’re extraordinarily grateful to our buyers for his or her confidence in Ronovo’s technique to democratize robotic surgical procedure,” said Dr. John Ma, founder, chair and CEO of Ronovo. “From inception, we have now stayed true to our perception that innovation should begin from an unique pursuit to unravel precise unmet scientific wants.”
Editor’s Word: This text first appeared on sister web site MassDevice.
